Prognostic significance of immune-related adverse events and immunosuppression in patients with melanoma receiving adjuvant anti-PD-1 therapy

被引：0
|
作者：
Knight, Andrew David
Karapetyan, Lilit
Bruno, Sabrina
Abushukair, Hassan Mohammed
Bo, Na
Wang, Hong
Sander, Cindy
Kirkwood, John M. M.
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[4] Jordan Univ Sci & Technol, Irbid, Jordan
[5] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA
[6] Univ Pittsburgh, Pittsburgh, PA USA
[7] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9580
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Serum multiplex analysis of checkpoint proteins in association with immune-related adverse events in patients with melanoma receiving adjuvant anti-PD-1 therapy
    Knight, Andrew David
    Bruno, Sabrina
    Layding, Caroline Jane
    Wang, Hong
    Sander, Cindy
    Storkus, Walter J.
    Karapetyan, Lilit
    Kirkwood, John M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Immune-related adverse events with resumed anti-PD-1 therapy
    [J]. Reactions Weekly, 2017, 1676 (1) : 4 - 4
  • [3] Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma
    Patrinely, J. Randall, Jr.
    Johnson, Rebecca
    Lawless, Aleigha R.
    Bhave, Prachi
    Sawyers, Amelia
    Dimitrova, Maya
    Yeoh, Hui Ling
    Palmeri, Marisa
    Ye, Fei
    Fan, Run
    Davis, Elizabeth J.
    Rapisuwon, Suthee
    Long, Georgina V.
    Haydon, Andrew
    Osman, Iman
    Mehnert, Janice M.
    Carlino, Matteo S.
    Sullivan, Ryan J.
    Menzies, Alexander M.
    Johnson, Douglas B.
    [J]. JAMA ONCOLOGY, 2021, 7 (05) : 744 - 748
  • [4] The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies
    Chiao-En Wu
    Chan-Keng Yang
    Meng-Ting Peng
    Pei-Wei Huang
    Ching-Fu Chang
    Kun-Yun Yeh
    Chun-Bing Chen
    Chih-Liang Wang
    Chao-Wei Hsu
    I-Wen Chen
    Cheng-Tao Lin
    Shir-Hwa Ueng
    Gigin Lin
    Yu-Fen Lin
    Chi-Yuan Cheng
    John Wen-Cheng Chang
    [J]. BMC Cancer, 20
  • [5] Anti-PD-1 antibodies: immune-related adverse events and efficacy
    [J]. Reactions Weekly, 2019, 1739 (1) : 6 - 6
  • [6] The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies
    Wu, Chiao-En
    Yang, Chan-Keng
    Peng, Meng-Ting
    Huang, Pei-Wei
    Chang, Ching-Fu
    Yeh, Kun-Yun
    Chen, Chun-Bing
    Wang, Chih-Liang
    Hsu, Chao-Wei
    Chen, I-Wen
    Lin, Cheng-Tao
    Ueng, Shir-Hwa
    Lin, Gigin
    Lin, Yu-Fen
    Cheng, Chi-Yuan
    Chang, John Wen-Cheng
    [J]. BMC CANCER, 2020, 20 (01)
  • [7] Immune-related adverse event recurrence with anti-PD-1 therapy
    [J]. Reactions Weekly, 2020, 1816 (1) : 8 - 8
  • [8] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    John A. McCulloch
    Diwakar Davar
    Richard R. Rodrigues
    Jonathan H. Badger
    Jennifer R. Fang
    Alicia M. Cole
    Ascharya K. Balaji
    Marie Vetizou
    Stephanie M. Prescott
    Miriam R. Fernandes
    Raquel G. F. Costa
    Wuxing Yuan
    Rosalba Salcedo
    Erol Bahadiroglu
    Soumen Roy
    Richelle N. DeBlasio
    Robert M. Morrison
    Joe-Marc Chauvin
    Quanquan Ding
    Bochra Zidi
    Ava Lowin
    Saranya Chakka
    Wentao Gao
    Ornella Pagliano
    Scarlett J. Ernst
    Amy Rose
    Nolan K. Newman
    Andrey Morgun
    Hassane M. Zarour
    Giorgio Trinchieri
    Amiran K. Dzutsev
    [J]. Nature Medicine, 2022, 28 : 545 - 556
  • [9] Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
    McCulloch, John A.
    Davar, Diwakar
    Rodrigues, Richard R.
    Badger, Jonathan H.
    Fang, Jennifer R.
    Cole, Alicia M.
    Balaji, Ascharya K.
    Vetizou, Marie
    Prescott, Stephanie M.
    Fernandes, Miriam R.
    Costa, Raquel G. F.
    Yuan, Wuxing
    Salcedo, Rosalba
    Bahadiroglu, Erol
    Roy, Soumen
    DeBlasio, Richelle N.
    Morrison, Robert M.
    Chauvin, Joe-Marc
    Ding, Quanquan
    Zidi, Bochra
    Lowin, Ava
    Chakka, Saranya
    Gao, Wentao
    Pagliano, Ornella
    Ernst, Scarlett J.
    Rose, Amy
    Newman, Nolan K.
    Morgun, Andrey
    Zarour, Hassane M.
    Trinchieri, Giorgio
    Dzutsev, Amiran K.
    [J]. NATURE MEDICINE, 2022, 28 (03) : 545 - +
  • [10] Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy
    Shafqat, Hammad
    Gourdin, Theodore
    Sion, Amy
    [J]. SEMINARS IN ONCOLOGY, 2018, 45 (03) : 156 - 163
12345